S100A1: A major player in cardiovascular performance

Physiological Research

Volumn 63, Issue 6, 2014, Pages 669-681

  Duarte Costa, S ^a   Castro Ferreira, R ^a   Neves, J S ^a   Leite Moreira, A F ^a,b  

^a University of Porto   (Portugal)

^b Centro Hospitalar Universitário de São João   (Portugal)

Author keywords

Calcium homeostasis; Contractile function; Endothelial dysfunction; Gene therapy; Heart failure

Indexed keywords

CALCIUM; PROTEIN S 100; S100A1 PROTEIN;

ANIMAL; CARDIOVASCULAR FUNCTION; GENE THERAPY; GENETICS; HEART CONTRACTION; HEART FAILURE; HOMEOSTASIS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CALCIUM; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; GENETIC THERAPY; HEART FAILURE; HOMEOSTASIS; HUMANS; MYOCARDIAL CONTRACTION; S100 PROTEINS;

EID: 84920472663     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. BERS DM: Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
2. BIANCHI R, GIAMBANCO I, DONATO R: S-100 protein, but not calmodulin, binds to the glial fibrillary acidic protein and inhibits its polymerization in a Ca(2+)-dependent manner. J Biol Chem 268: 12669-12674, 1993.
3. BIRKELAND JA, SEJERSTED OM, TARALDSEN T, SJAASTAD I: EC-coupling in normal and failing hearts. Scand Cardiovasc J 39: 13-23, 2005.
4. BOERRIES M, MOST P, GLEDHILL JR, WALKER JE, KATUS HA, KOCH WJ, AEBI U, SCHOENENBERGER CA: Ca2+ -dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes. Mol Cell Biol 27: 4365-4373, 2007.
5. BORBELY A, FALCAO-PIRES I, VAN HEEREBEEK L, HAMDANI N, EDES I, GAVINA C, LEITE-MOREIRA AF, BRONZWAER JG, PAPP Z, VAN DER VELDEN J, STIENEN GJ, PAULUS WJ: Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res 104: 780-786, 2009.
6. BRINKS H, ROHDE D, VOELKERS M, QIU G, PLEGER ST, HERZOG N, RABINOWITZ J, RUHPARWAR A, SILVESTRY S, LERCHENMULLER C, MATHER PJ, ECKHART AD, KATUS HA, CARREL T, KOCH WJ, MOST P: S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes. J Am Coll Cardiol 58: 966-973, 2011.
7. CASTRO-FERREIRA R, FONTES-CARVALHO R, FALCAO-PIRES I, LEITE-MOREIRA AF: The role of titin in the modulation of cardiac function and its pathophysiological implications. Arq Bras Cardiol 96: 332-339, 2011.
8. DESJARDINS JF, POURDJABBAR A, QUAN A, LEONG-POI H, TEICHERT-KULISZEWSKA K, VERMA S, PARKER TG: Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction. Am J Physiol Heart Circ Physiol 296: H1457-H1465, 2009.
9. DROHAT AC, BALDISSERI DM, RUSTANDI RR, WEBER DJ: Solution structure of calcium-bound rat S100B(betabeta) as determined by nuclear magnetic resonance spectroscopy. Biochemistry 37: 2729-2740, 1998.
10. DU XJ, COLE TJ, TENIS N, GAO XM, KONTGEN F, KEMP BE, HEIERHORST J: Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice. Mol Cell Biol 22: 2821-2829, 2002.
11. EHLERMANN P, REMPPIS A, GUDDAT O, WEIMANN J, SCHNABEL PA, MOTSCH J, HEIZMANN CW, KATUS HA: Right ventricular upregulation of the Ca(2+) binding protein S100A1 in chronic pulmonary hypertension. Biochim Biophys Acta 1500: 249-255, 2000.
12. FLEMING I, BUSSE R: Signal transduction of eNOS activation. Cardiovasc Res 43: 532-541, 1999.
13. FLEMING I, FISSLTHALER B, DIMMELER S, KEMP BE, BUSSE R: Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88: E68-E75, 2001.
14. FUKUSHIMA H, CHUNG CS, GRANZIER H: Titin-isoform dependence of titin-actin interaction and its regulation by S100A1/Ca2+ in skinned myocardium. J Biomed Biotechnol 2010: 727239, 2010.
15. HAIMOTO H, KATO K: S100a0 (alpha alpha) protein in cardiac muscle. Isolation from human cardiac muscle and ultrastructural localization. Eur J Biochem 171: 409-415, 1988.
16. INGWALL JS, WEISS RG: Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95: 135-145, 2004.
17. KETTLEWELL S, MOST P, CURRIE S, KOCH WJ, SMITH GL: S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes. J Mol Cell Cardiol 39: 900-910, 2005.
18. KIEWITZ R, ACKLIN C, MINDER E, HUBER PR, SCHAFER BW, HEIZMANN CW: S100A1, a new marker for acute myocardial ischemia. Biochem Biophys Res Commun 274: 865-871, 2000.
19. KIEWITZ R, ACKLIN C, SCHAFER BW, MACO B, UHRIK B, WUYTACK F, ERNE P, HEIZMANN CW: Ca 2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart. Biochem Biophys Res Commun 306: 550-557, 2003.
20. KRAUS C, ROHDE D, WEIDENHAMMER C, QIU G, PLEGER ST, VOELKERS M, BOERRIES M, REMPPIS A, KATUS HA, MOST P: S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy. J Mol Cell Cardiol 47: 445-455, 2009.
21. LENARCIC ZIVKOVIC M, ZAREBA-KOZIOL M, ZHUKOVA L, POZNANSKI J, ZHUKOV I, WYSLOUCHCIESZYNSKA A: Post-translational S-nitrosylation is an endogenous factor fine tuning the properties of human S100A1 protein. J Biol Chem 287: 40457-40470, 2012.
22. LOHSE MJ, ENGELHARDT S, ESCHENHAGEN T: What is the role of beta-adrenergic signaling in heart failure? Circ Res 93: 896-906, 2003.
23. LOKUTA AJ, MAERTZ NA, MEETHAL SV, POTTER KT, KAMP TJ, VALDIVIA HH, HAWORTH RA: Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure. Circulation 111: 988-995, 2005.
24. LOMPRE AM, HAJJAR RJ, HARDING SE, KRANIAS EG, LOHSE MJ, MARKS AR: Ca2+ cycling and new therapeutic approaches for heart failure. Circulation 121: 822-830, 2010.
25. MARENHOLZ I, HEIZMANN CW, FRITZ G: S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322: 1111-1122, 2004.
26. MOORE BW: A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 19: 739-744, 1965.
27. MOST P, BERNOTAT J, EHLERMANN P, PLEGER ST, REPPEL M, BORRIES M, NIROOMAND F, PIESKE B, JANSSEN PM, ESCHENHAGEN T, KARCZEWSKI P, SMITH GL, KOCH WJ, KATUS HA, REMPPIS A: S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci USA 98: 13889-13894, 2001.
28. MOST P, BOERRIES M, EICHER C, SCHWEDA C, EHLERMANN P, PLEGER ST, LOEFFLER E, KOCH WJ, KATUS HA, SCHOENENBERGER CA, REMPPIS A: Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2). J Biol Chem 278: 48404-48412, 2003.
29. MOST P, REMPPIS A, PLEGER ST, LOFFLER E, EHLERMANN P, BERNOTAT J, KLEUSS C, HEIERHORST J, RUIZ P, WITT H, KARCZEWSKI P, MAO L, ROCKMAN HA, DUNCAN SJ, KATUS HA, KOCH WJ: Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J Biol Chem 278: 33809-33817, 2003.
30. MOST P, PLEGER ST, VOLKERS M, HEIDT B, BOERRIES M, WEICHENHAN D, LOFFLER E, JANSSEN PM, ECKHART AD, MARTINI J, WILLIAMS ML, KATUS HA, REMPPIS A, KOCH WJ: Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest 114: 1550-1563, 2004.
31. MOST P, BOERRIES M, EICHER C, SCHWEDA C, VOLKERS M, WEDEL T, SOLLNER S, KATUS HA, REMPPIS A, AEBI U, KOCH WJ, SCHOENENBERGER CA: Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes. J Cell Sci 118: 421-431, 2005.
32. MOST P, SEIFERT H, GAO E, FUNAKOSHI H, VOLKERS M, HEIERHORST J, REMPPIS A, PLEGER ST, DEGEORGE BR JR, ECKHART AD, FELDMAN AM, KOCH WJ: Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation 114: 1258- 1268, 2006.
33. MOST P, LERCHENMULLER C, RENGO G, MAHLMANN A, RITTERHOFF J, ROHDE D, GOODMAN C, BUSCH CJ, LAUBE F, HEISSENBERG J, PLEGER ST, WEISS N, KATUS HA, KOCH WJ, PEPPEL K: S100A1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation. Circ Res 112: 66-78, 2013.
34. MOST P, RAAKE P, WEBER C, KATUS HA, PLEGER ST: S100A1 gene therapy in small and large animals. Methods Mol Biol 963: 407-420, 2013.
35. OTTERBEIN LR, KORDOWSKA J, WITTE-HOFFMANN C, WANG CL, DOMINGUEZ R: Crystal structures of S100A6 in the Ca(2+)-free and Ca(2+)-bound states: the calcium sensor mechanism of S100 proteins revealed at atomic resolution. Structure 10: 557-567, 2002.
36. PLEGER ST, REMPPIS A, HEIDT B, VOLKERS M, CHUPRUN JK, KUHN M, ZHOU RH, GAO E, SZABO G, WEICHENHAN D, MULLER OJ, ECKHART AD, KATUS HA, KOCH WJ, MOST P: S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. Mol Ther 12: 1120-1129, 2005.
37. PLEGER ST, MOST P, BOUCHER M, SOLTYS S, CHUPRUN JK, PLEGER W, GAO E, DASGUPTA A, RENGO G, REMPPIS A, KATUS HA, ECKHART AD, RABINOWITZ JE, KOCH WJ: Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation 115: 2506-2515, 2007.
38. PLEGER ST, HARRIS DM, SHAN C, VINGE LE, CHUPRUN JK, BERZINS B, PLEGER W, DRUCKMAN C, VOLKERS M, HEIERHORST J, OIE E, REMPPIS A, KATUS HA, SCALIA R, ECKHART AD, KOCH WJ, MOST P: Endothelial S100A1 modulates vascular function via nitric oxide. Circ Res 102: 786-794, 2008.
39. PLEGER ST, SHAN C, KSIENZYK J, BEKEREDJIAN R, BOEKSTEGERS P, HINKEL R, SCHINKEL S, LEUCHS B, LUDWIG J, QIU G, WEBER C, RAAKE P, KOCH WJ, KATUS HA, MULLER OJ, MOST P: Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci Transl Med 3: 92ra64, 2011.
40. PROSSER BL, HERNANDEZ-OCHOA EO, SCHNEIDER MF: S100A1 and calmodulin regulation of ryanodine receptor in striated muscle. Cell Calcium 50: 323-331, 2011.
41. REMPPIS A, GRETEN T, SCHAFER BW, HUNZIKER P, ERNE P, KATUS HA, HEIZMANN CW: Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta 1313: 253-257, 1996.
42. REPPEL M, SASSE P, PIEKORZ R, TANG M, ROELL W, DUAN Y, KLETKE A, HESCHELER J, NURNBERG B, FLEISCHMANN BK: S100A1 enhances the L-type Ca2+ current in embryonic mouse and neonatal rat ventricular cardiomyocytes. J Biol Chem 280: 36019-36028, 2005.
43. REPPEL M, FLEISCHMANN BK, REUTER H, PILLEKAMP F, SCHUNKERT H, HESCHELER J: Regulation of Na+/Ca2+ exchange current in the normal and failing heart. Ann NY Acad Sci 1099: 361-372, 2007.
44. Roger Vl, Go As, Lloyd-Jones Dm, Benjamin Ej, Berry Jd, Borden Wb, Bravata Dm, DAI S, FORD ES, FOX CS, FULLERTON HJ, GILLESPIE C, HAILPERN SM, HEIT JA, HOWARD VJ, KISSELA,Ford Es, Fox Cs, Fullerton Hj, Gillespie C, Hailpern Sm, Heit Ja, Howard Vj, KISSELA BM, KITTNER SJ, LACKLAND DT, LICHTMAN JH, LISABETH LD, MAKUC DM, MARCUS GM, MARELLI A, MATCHAR DB, MOY CS, MOZAFFARIAN D, MUSSOLINO ME, NICHOL G, PAYNTER NP, SOLIMAN EZ, SORLIE PD, SOTOODEHNIA N, TURAN TN, VIRANI SS, WONG ND, WOO D, TURNER MB, AMERICAN HEART ASSOCIATION STATISTICS C, STROKE STATISTICS S: Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 125: e2-e220, 2012.
45. ROHDE D, BRINKS H, RITTERHOFF J, QUI G, REN S, MOST P: S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trials. J Mol Cell Cardiol 50: 777-784, 2011.
46. SMITH SP, SHAW GS: A change-in-hand mechanism for S100 signalling. Biochem Cell Biol 76: 324-333, 1998.
47. TSOPORIS JN, MARKS A, ZIMMER DB, MCMAHON C, PARKER TG: The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart. Mol Cell Biochem 242: 27-33, 2003.
48. VENTURA-CLAPIER R, GARNIER A, VEKSLER V: Energy metabolism in heart failure. J Physiol 555: 1-13, 2004.
49. VINGE LE, RAAKE PW, KOCH WJ: Gene therapy in heart failure. Circ Res 102: 1458-1470, 2008.
50. VOLKERS M, ROHDE D, GOODMAN C, MOST P: S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function. J Biomed Biotechnol 2010: 178614, 2010.
51. WEBER C, NEACSU I, KRAUTZ B, SCHLEGEL P, SAUER S, RAAKE P, RITTERHOFF J, JUNGMANN A, REMPPIS AB, STANGASSINGER M, KOCH WJ, KATUS HA, MULLER OJ, MOST P, PLEGER ST: Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model. Gene Ther 21: 131-138, 2014.
52. WRIGHT NT, VARNEY KM, ELLIS KC, MARKOWITZ J, GITTI RK, ZIMMER DB, WEBER DJ: The threedimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy. J Mol Biol 353: 410-426, 2005.
53. WRIGHT NT, PROSSER BL, VARNEY KM, ZIMMER DB, SCHNEIDER MF, WEBER DJ: S100A1 and calmodulin compete for the same binding site on ryanodine receptor. J Biol Chem 283: 26676-26683, 2008.
54. WRIGHT NT, CANNON BR, ZIMMER DB, WEBER DJ: S100A1: Structure, function, and therapeutic potential. Curr Chem Biol 3: 138-145, 2009.
55. YAMASAKI R, BERRI M, WU Y, TROMBITAS K, MCNABB M, KELLERMAYER MS, WITT C, LABEIT D, LABEIT S, GREASER M, GRANZIER H: Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1. Biophys J 81: 2297-2313, 2001.